Shareholders that lost money on Revance Therapeutics, Inc.(RVNC) should contact Levi & Korsinsky about Securities Fraud Investigation - RVNC
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Revance Therapeutics, Inc. (NASDAQ:RVNC) for potential violations of federal securities laws. This follows Revance's disclosure of a notice to remedy alleged breaches in its distribution agreement with Teoxane SA.
November 11, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Revance Therapeutics is under investigation for potential securities law violations related to alleged breaches in its distribution agreement with Teoxane SA.
The investigation by Levi & Korsinsky into Revance Therapeutics for potential securities law violations is significant. The alleged breaches in the distribution agreement with Teoxane SA could lead to legal and financial repercussions, negatively impacting investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100